Table 1 Comparison of participants with and without HIVDR testing
Participants | P | ||
|---|---|---|---|
No HIVDR testing | HIVDR testing | ||
n | 1235 | 197 | |
Sex (%) | |||
Female | 692 (56.0) | 122 (61.9) | 0.140a |
Male | 543 (44.0) | 75 (38.1) | |
Age [mean (SD)] | 36.20 (9.31) | 35.09 (9.11) | 0.118b |
BMI [mean (SD)] | 24.28 (4.91) | 23.93 (4.63) | 0.348b |
WHO stage (%) | |||
1 | 531 (43.0) | 128 (65.0) | < 0.001a |
2 | 183 (14.8) | 38 (19.3) | |
3 | 429 (34.7) | 19 (9.6) | |
4 | 92 (7.4) | 12 (6.1) | |
CD4 count (median [IQR]) | 269.5 [125; 420] | 247.5 [89; 420] | 0.230c |
Viral load (median [IQR]) | 33 000 [6 696; 140 844] | 112 599 [21 318; 454 638] | < 0.001c |
Outcome (%) | |||
Alive on ART | 715 (57.9) | 119 (60.4) | 0.020a |
Defaulted | 267 (21.6) | 32 (16.2) | |
Transferred out | 118 (9.6) | 21 (10.7) | |
Changed ART regimen | 62 (5.0) | 3 (1.5) | |
Died | 41 (3.3) | 14 (7.1) | |
Withdrawn | 27 (2.2) | 7 (3.6) | |
Stopped ART | 5 (0.4) | 1 (0.5) | |